ArticleNuclear medicine and biology2015

Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.

Yinnong Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.